Latest Breaking News On - Alzheimer drug discovery foundation - Page 1 : comparemela.com

Donanemab for Alzheimer's Gets Thumbs Up From FDA Panel

An 11-member advisory panel to the US Food and Drug Administration unanimously endorsed the anti-amyloid donanemab for early Alzheimer's disease.

Eli Lilly's Alzheimer's Drug Gains Unanimous FDA Panel Backing

FDA Panel Endorses Donanemab to Treat Early-Stage Alzheimer Disease

Donanemab was able to significantly slow clinical progression of Alzheimer disease and amyloid and tau pathology at 76 weeks of treatment.

Alzheimer's drug from Eli Lilly wins backing of FDA committee

An advisory committee to the Food and Drug Administration found the drug was safe and effective at slowing the progression of the disease, setting the stage for the agency to approve it.

CARINGKIND'S 28TH ANNUAL FORGET-ME-NOT GALA TO HONOR LEADERS IN AI, SCIENCE, AND CULTURE

/PRNewswire/ CaringKind, the trusted partner in Alzheimer s and dementia caregiving for over 45 years, proudly announces their 28th annual Forget-Me-Not.